These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 34617531)

  • 21. Zhankuic Acids A, B and C from
    Teng YN; Wang YH; Wu TS; Hung HY; Hung CC
    Biomolecules; 2019 Nov; 9(12):. PubMed ID: 31766413
    [No Abstract]   [Full Text] [Related]  

  • 22. Tariquidar (XR9576): a P-glycoprotein drug efflux pump inhibitor.
    Fox E; Bates SE
    Expert Rev Anticancer Ther; 2007 Apr; 7(4):447-59. PubMed ID: 17428165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of regional differences in tariquidar-induced P-glycoprotein modulation at the human blood-brain barrier.
    Bauer M; Karch R; Neumann F; Wagner CC; Kletter K; Müller M; Löscher W; Zeitlinger M; Langer O
    J Cereb Blood Flow Metab; 2010 Mar; 30(3):510-5. PubMed ID: 20010957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tariquidar sensitizes multiple myeloma cells to proteasome inhibitors via reduction of hypoxia-induced P-gp-mediated drug resistance.
    Muz B; Kusdono HD; Azab F; de la Puente P; Federico C; Fiala M; Vij R; Salama NN; Azab AK
    Leuk Lymphoma; 2017 Dec; 58(12):2916-2925. PubMed ID: 28509582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and Characterization of Bodipy-FL-Cyclosporine A as a Substrate for Multidrug Resistance-Linked P-Glycoprotein (ABCB1).
    Sajid A; Raju N; Lusvarghi S; Vahedi S; Swenson RE; Ambudkar SV
    Drug Metab Dispos; 2019 Oct; 47(10):1013-1023. PubMed ID: 31371421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tariquidar inhibits P-glycoprotein drug efflux but activates ATPase activity by blocking transition to an open conformation.
    Loo TW; Clarke DM
    Biochem Pharmacol; 2014 Dec; 92(4):558-66. PubMed ID: 25456855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Folate-Targeted Redox-Responsive Polymersomes Loaded with Chemotherapeutic Drugs and Tariquidar to Overcome Drug Resistance.
    Qin Y; Zhang Z; Huang C; Fan F; Liu L; Lu L; Wang H; Liu Z; Yang J; Wang C; Yang H; Sun H; Leng X; Kong D; Zhang L; Zhu D
    J Biomed Nanotechnol; 2018 Oct; 14(10):1705-1718. PubMed ID: 30041718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A phase I study of the P-glycoprotein antagonist tariquidar in combination with vinorelbine.
    Abraham J; Edgerly M; Wilson R; Chen C; Rutt A; Bakke S; Robey R; Dwyer A; Goldspiel B; Balis F; Van Tellingen O; Bates SE; Fojo T
    Clin Cancer Res; 2009 May; 15(10):3574-82. PubMed ID: 19417029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measurement of Hepatic ABCB1 and ABCG2 Transport Activity with [
    Hernández Lozano I; Bauer M; Wulkersdorfer B; Traxl A; Philippe C; Weber M; Häusler S; Stieger B; Jäger W; Mairinger S; Wanek T; Hacker M; Zeitlinger M; Langer O
    Mol Pharm; 2020 Jan; 17(1):316-326. PubMed ID: 31790256
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enabling P-glycoprotein inhibition in multidrug resistant cancer through the reverse targeting of a quinidine-PEG conjugate.
    Snyder S; Murundi S; Crawford L; Putnam D
    J Control Release; 2020 Jan; 317():291-299. PubMed ID: 31770573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversal of MRP7 (ABCC10)-mediated multidrug resistance by tariquidar.
    Sun YL; Chen JJ; Kumar P; Chen K; Sodani K; Patel A; Chen YL; Chen SD; Jiang WQ; Chen ZS
    PLoS One; 2013; 8(2):e55576. PubMed ID: 23393594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potent and selective inhibitors of breast cancer resistance protein (ABCG2) derived from the p-glycoprotein (ABCB1) modulator tariquidar.
    Kühnle M; Egger M; Müller C; Mahringer A; Bernhardt G; Fricker G; König B; Buschauer A
    J Med Chem; 2009 Feb; 52(4):1190-7. PubMed ID: 19170519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Caffeic Acid Attenuates Multi-Drug Resistance in Cancer Cells by Inhibiting Efflux Function of Human P-glycoprotein.
    Teng YN; Wang CCN; Liao WC; Lan YH; Hung CC
    Molecules; 2020 Jan; 25(2):. PubMed ID: 31936160
    [No Abstract]   [Full Text] [Related]  

  • 34. Noninvasive functional imaging of P-glycoprotein-mediated doxorubicin resistance in a mouse model of hereditary breast cancer to predict response, and assign P-gp inhibitor sensitivity.
    van Leeuwen FW; Buckle T; Kersbergen A; Rottenberg S; Gilhuijs KG
    Eur J Nucl Med Mol Imaging; 2009 Mar; 36(3):406-12. PubMed ID: 19093112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purine nucleoside analog--sulfinosine modulates diverse mechanisms of cancer progression in multi-drug resistant cancer cell lines.
    Dačević M; Isaković A; Podolski-Renić A; Isaković AM; Stanković T; Milošević Z; Rakić L; Ruždijić S; Pešić M
    PLoS One; 2013; 8(1):e54044. PubMed ID: 23326571
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Marine sponge-derived sipholane triterpenoids reverse P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells.
    Abraham I; Jain S; Wu CP; Khanfar MA; Kuang Y; Dai CL; Shi Z; Chen X; Fu L; Ambudkar SV; El Sayed K; Chen ZS
    Biochem Pharmacol; 2010 Nov; 80(10):1497-506. PubMed ID: 20696137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. (18)F-FCWAY, a serotonin 1A receptor radioligand, is a substrate for efflux transport at the human blood-brain barrier.
    Liow JS; Zoghbi SS; Hu S; Hall MD; Hines CS; Shetty HU; Araneta MD; Page EM; Pike VW; Kreisl WC; Herscovitch P; Gottesman MM; Theodore WH; Innis RB
    Neuroimage; 2016 Sep; 138():134-140. PubMed ID: 27211474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. P-glycoprotein function at the blood-brain barrier in humans can be quantified with the substrate radiotracer 11C-N-desmethyl-loperamide.
    Kreisl WC; Liow JS; Kimura N; Seneca N; Zoghbi SS; Morse CL; Herscovitch P; Pike VW; Innis RB
    J Nucl Med; 2010 Apr; 51(4):559-66. PubMed ID: 20237038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HG-829 is a potent noncompetitive inhibitor of the ATP-binding cassette multidrug resistance transporter ABCB1.
    Caceres G; Robey RW; Sokol L; McGraw KL; Clark J; Lawrence NJ; Sebti SM; Wiese M; List AF
    Cancer Res; 2012 Aug; 72(16):4204-13. PubMed ID: 22761337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and Anticancer Cytotoxicity of Azaaurones Overcoming Multidrug Resistance.
    Tóth S; Szepesi Á; Tran-Nguyen VK; Sarkadi B; Német K; Falson P; Di Pietro A; Szakács G; Boumendjel A
    Molecules; 2020 Feb; 25(3):. PubMed ID: 32050702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.